EMA Authorised: Tadalafil Lilly (tadalafil) — Eli Lilly Nederland B.V.

View source ↗

Summary

The EMA authorised a tadalafil product from Eli Lilly Nederland B.V. for erectile dysfunction, with decision date 27 January 2026.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Tadalafil Lilly (tadalafil)

Snippet

Status: Authorised. Therapeutic area: Erectile Dysfunction. MAH: Eli Lilly Nederland B.V.. Decision date: 27/01/2026